EV/EBITDA:
-2.77+0.10(+3.48%)Summary
- As of today (September 18, 2025), RXRX EV/EBITDA is -2.77, with a rise of +0.10 (+3.48%) during the most recent trading session on September 17, 2025.
- Over the past year, RXRX EV/EBITDA has increased by +1.72 (+38.31%).
- RXRX EV/EBITDA is now -68.90% below its all-time high of -1.64.
Performance
RXRX EV/EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
EV/EBITDA Formula
EV/EBITDA = Enterprise Value
TTM EBITDA
Enterprise Value
TTM EBITDA
TTM EBITDA
RXRX EV/EBITDA Trends
| PeriodPeriod | EV/EBITDAEV/EBITDA | Enterprise valueEnterprise value | PricePrice |
|---|---|---|---|
| todaytoday | +3.5% | -3.4% | -2.7% |
| 1 m1 month | +17.3% | -17.4% | -14.7% |
| 3 m3 months | +12.9% | -3.0% | -7.8% |
| 6 m6 months | +43.1% | -22.3% | -26.3% |
| ytdytd | +46.1% | -26.3% | -30.3% |
| 1 y1 year | +38.3% | +3.3% | -31.8% |
| 5 y5 years | - | - | - |
RXRX EV/EBITDA Highs & Lows
| PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
|---|---|---|---|---|---|
| 1 m | 1-month | -2.63 | -5.3% | -3.35 | +17.3% |
| 3 m | 3-month | -2.63 | -5.3% | -4.10 | +32.4% |
| 6 m | 6-month | -2.29 | -21.0% | -5.25 | +47.2% |
| 1 y | 1-year | -2.29 | -21.0% | -9.09 | +69.5% |
| 3 y | 3-year | -1.93 | -43.5% | -11.70 | +76.3% |
| 5 y | 5-year | -1.64 | -68.9% | -65.13 | +95.8% |
| alltime | all time | -1.64 | -68.9% | -65.13 | +95.8% |
RXRX EV/EBITDA History
| Date | Value |
|---|---|
| 2025 | -2.77(-46.1%) |
| 2024 | -5.14(-19.4%) |
| Date | Value |
|---|---|
| 2023 | -6.38(+49.4%) |
| 2022 | -4.27(-69.0%) |
| 2021 | -13.76 |
FAQ
- What is Recursion Pharmaceuticals, Inc. EV/EBITDA?
- What is the all time high EV/EBITDA for Recursion Pharmaceuticals, Inc.?
- What is RXRX EV/EBITDA year-to-date change?
- What is Recursion Pharmaceuticals, Inc. EV/EBITDA year-on-year change?
What is Recursion Pharmaceuticals, Inc. EV/EBITDA?
The current EV/EBITDA of RXRX is -2.77
What is the all time high EV/EBITDA for Recursion Pharmaceuticals, Inc.?
Recursion Pharmaceuticals, Inc. all-time high EV/EBITDA is -1.64
What is RXRX EV/EBITDA year-to-date change?
Recursion Pharmaceuticals, Inc. EV/EBITDA has changed by +2.37 (+46.11%) since the beginning of the year
What is Recursion Pharmaceuticals, Inc. EV/EBITDA year-on-year change?
Over the past year, RXRX EV/EBITDA has changed by +1.72 (+38.31%)